Huntington's chorea (also known as St. Vitus' dance) is a rare brain disorder that causes, among other symptoms, uncontrollable, jerky movements in individuals. Photo: Getty Images/Science Photo ...
SAN DIEGO, Oct. 6, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the open-label KINECT ®-HD2 study demonstrating an established long-term safety ...
However, in late September 2025, scientists successfully treated Huntington’s for the first time in a ground-breaking study.
SOM Biotech, a clinical-stage company dedicated to the discovery and development of innovative therapies for rare central nervous system disorders, announces today that it has received the final ...
The United States Huntington's Disease Treatment Market is set to expand significantly, with an expected CAGR of 15.22% from ...
Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...
Neurocrine Biosciences shows strong growth with rising INGREZZA sales, expanding pipeline, and solid financials despite key ...
Health and Me on MSN
Is Huntington’s Disease Genetic? Here’s Everything You Should Know
Huntington’s disease is a hereditary brain disorder that impacts movement, mood, and cognitive abilities. It gets worse over time, though recent advances in gene therapy have brought new hope for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback